Differentiation of prostate cancer and stromal hyperplasia in the transition zone with histogram analysis of the apparent diffusion coefficient

Abstract

Background

Prostate cancer and stromal hyperplasia (SH) in the transition zone (TZ) are difficult to discriminate by conventional magnetic resonance imaging (MRI) and diffusion-weighted imaging (DWI).

Purpose

To investigate the apparent diffusion coefficient (ADC) of prostate cancer and SH in the TZ with histogram analysis and the ability of ADC metrics to differentiate between these two tissues.

Material and Methods

Thirty-three cancer and 29 SH lesions in the TZ of 54 patients undergoing preoperative DWI (b-value 0, 1000 s/mm²) were analyzed. All the lesions on the MR images were localized based on histopathologic correlations. The 10th, 25th, and 50th percentiles, and the mean ADC values were calculated for the two tissues and compared. The efficiencies of the 10th, 25th, and 50th ADC percentiles in differentiating the two tissues were compared with that of the mean ADC with receiver operating characteristic (ROC) analysis.

Results

The 10th, 25th, and 50th percentiles and mean ADC values (×10⁻³ mm²/s) were 0.86 ± 0.15, 0.89 ± 0.16, 0.94 ± 0.16, and 1.03 ± 0.17 in SH and 0.64 ± 0.12, 0.69 ± 0.12, 0.72 ± 0.16, and 0.83 ± 0.15 in TZ cancer, respectively. The parameters were all significantly lower in cancer than SH. The 10th ADC percentile yielded an area under the ROC curve (AUC) of 0.87 for the differentiation of carcinomas from SH, which was higher than the mean ADC (0.80) (P < 0.05), and the AUCs of the 25th (0.82) and 50th (0.83) percentiles exhibited no differences from those of the mean ADC (P > 0.05).

Conclusion

Histogram analysis of ADC values may potentially improve the differentiation of prostate cancer from SH in the TZ.

Keywords

Magnetic resonance (MR) diffusion/perfusion prostate neoplasms – primary

Get full access to this article

View all access options for this article.

References

McNeal

Redwine

Freiha

et al.

Zonal distribution of prostatic adenocarcinoma. Correlation with histologic pattern and direction of spread. Am J Surg Pathol 1988; 12: 897–906.

Yoshizako

Wada

Hayashi

et al.

Usefulness of diffusion-weighted imaging and dynamic contrast-enhanced magnetic resonance imaging in the diagnosis of prostate transition-zone cancer. Acta Radiol 2008; 49: 1207–1213.

Rosenkrantz

Kim

Campbell

et al.

Transition zone prostate cancer: revisiting the role of multiparametric MRI at 3T. Am J Roentgenol 2015; 204: W266–W272.

Oto

Kayhan

Jiang

et al.

Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology 2010; 257: 715–723.

Elbuluk

Muradyan

Shih

et al.

Differentiating transition zone cancers from benign prostatic hyperplasia by quantitative multiparametric magnetic resonance imaging. J Comput Assist Tomogr 2016; 40: 218–224.

Noworolski

Vigneron

Chen

et al.

Dynamic contrast-enhanced MRI and MR diffusion imaging to distinguish between glandular and stromal prostatic tissues. Magn Reson Imaging 2008; 26: 1071–1080.

Wetter

Nensa

Lipponer

et al.

High and ultra-high b-value diffusion-weighted imaging in prostate cancer: a quantitative analysis. Acta Radiol 2015; 56: 1009–1015.

Xue

Ren

Yang

et al.

Histogram analysis of apparent diffusion coefficient for the assessment of local aggressiveness of cervical cancer. Arch Gynecol Obstet 2014; 290: 341–348.

Suo

Zhang

Cao

et al.

Characterization of breast masses as benign or malignant at 3.0T MRI with whole-lesion histogram analysis of the apparent diffusion coefficient. J Magn Reson Imaging 2016; 43: 894–902.

10.

Liu

Zhou

Peng

et al.

Differentiation of central gland prostate cancer from benign prostatic hyperplasia using monoexponential and biexponential diffusion-weighted imaging. Magn Reson Imaging 2013; 31: 1318–1324.

11.

Rosenkrantz

Kong

Niver

et al.

Prostate cancer: comparison of tumor visibility on trace diffusion-weighted images and the apparent diffusion coefficient map. Am J Roentgenol 2011; 196: 123–129.

12.

Ishida

Sugimura

Okizuka

et al.

Benign prostatic hyperplasia: value of MR imaging for determining histologic type. Radiology 1994; 190: 329–331.

13.

Donati

Mazaheri

Afaq

et al.

Prostate cancer aggressiveness: assessment with whole-lesion histogram analysis of the apparent diffusion coefficient. Radiology 2014; 271: 143–152.

14.

Peng

Jiang

Yang

et al.

Quantitative analysis of multiparametric prostate MR images: differentiation between prostate cancer and normal tissue and correlation with Gleason score–a computer-aided diagnosis development study. Radiology 2013; 267: 787–796.

15.

Borren

Moman

Groenendaal

et al.

Why prostate tumour delineation based on apparent diffusion coefficient is challenging: an exploration of the tissue microanatomy. Acta Oncol 2013; 52: 1629–1636.

16.

Chagas

Babinski

Costa

et al.

Stromal and acinar components of the transition zone in normal and hyperplastic human prostate. Bju Int 2002; 89: 699–702.